Scientists test 'Targeted Radiation' drug combo in fight against advanced kidney cancer
NCT ID NCT05663710
Summary
This study is testing a new three-drug combination for people newly diagnosed with advanced clear cell kidney cancer. The goal is to see if adding a targeted radiation drug to two existing cancer drugs is safe and can help control the disease. Researchers will enroll about 100 patients to measure side effects and see how well the treatment shrinks tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.